When cancer patients with primary tumors were compared to those with recurrent tumors, primary tumors exhibited significantly higher concentrations of HMGB1 (p < 0.001) and a higher HMGB1/sRAGE ratio (p < 0.001) than recurrent tumors, as given in Table 2. This evidence concerns the gene HMGB1 and cancer.